Intellectual property protection in India and implications for health innovation: emerging perspectives

Basant, Rakesh; Srinivasan, Shuchi

doi:10.2147/ieh.s56236

Cited by 7 publications

(5 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The links between IP regime and innovation activity are complex. While it is not possible to attribute all types of innovations to changes in the IP regime, there is evidence to a variety of innovations in the health sector in India after the introduction of a more stringent TRIPS compatible regime (Basant & Srinivasan, 2016). As expected, another study on India suggests that the impact of such reforms is higher in 'IP sensitive' industries like non-electrical machinery and drugs and pharmaceuticals than in other industries (Kanwar, 2013).…”

Section: Intellectual Property Rights (Ipr) Policymentioning

confidence: 94%

Exploring Linkages between Industrial Innovation and Public Policy: Challenges and Opportunities

Basant

2018

Vikalpa

Self Cite

View full text Add to dashboard Cite

PERSPECTIVES presents emerging issues and ideas that call for action orrethinking by managers, administrators, and policy makers in organizations It is widely understood now that innovation is critical for development and growth of an economy. World over, governments have worked with a variety of policies to encourage innovative activity. Significant research has gone into the analysis of the complex linkages between public policy and innovation. While this research has generated a lot of interesting insights, it has also identified several gaps in our understanding of these linkages. This article is an attempt to pool together some of the ideas that academic research has highlighted on the linkages between innovation and public policy and identify the current challenges as well as opportunities for meaningfully exploring these linkages further. While it draws a lot on existing studies, the article does not provide a comprehensive or rigorous review of the literature on this subject. It is, at best, a tentative attempt to provide a broad perspective on where we stand vis-à-vis our understanding on the relationship between innovation and public policy. And admittedly, it is one of the many perspectives that a researcher can potentially have on this complex relationship.The article is divided into seven sections. The first section provides a broad overview of the public policy-innovation interface (focusing more on industrial innovation) which the subsequent sections flesh out in some detail. The definitions of innovation and the perspective taken are deliberated upon. This is followed by a discussion of firm activities and choices that are related to innovation. The salient mechanisms through which public policy affects innovation through these choices are spelt out in the next section. This discussion is taken further by reviewing how various specific policies impinge on innovation through different mechanisms. The next section summarizes the issues relating to measurement while innovationpublic policy linkages are analysed. The final section concludes with a brief discussion of potential areas of work in the context of India.

show abstract

Section: Intellectual Property Rights (Ipr) Policymentioning

confidence: 94%

Exploring Linkages between Industrial Innovation and Public Policy: Challenges and Opportunities

Basant

2018

Vikalpa

Self Cite

View full text Add to dashboard Cite

show abstract

“…Indian Patent Office opposes the concept of "evergreening" which is a practice of inventors of patented products for extending their monopoly period by various strategies (for example over associated delivery systems, or new pharmaceutical mixtures, etc.) [36,37]. Section 3(e).…”

Section: Case 4: Patent Application Entitled "Gene Family (Lbfl313) Associated With Pancreatic Cancer"mentioning

confidence: 99%

Case Study on Rejected Patents in India

Patel¹,

Lodha²

2020

Intellectual Property Rights - Patent

View full text Add to dashboard Cite

India is a country that has understood the importance of strong patent systems for the growth of industry and commerce to bring it at par with the modern world. As per WIPO statistical database September 2018, 45,379 patent applications were filed in India. Out of which, 12,387 applications were granted and 29,789 applications were withdrawn or abandoned by the applicants. About 3203 patents were rejected on the ground of non-fulfillment of patentability criteria by the invention, that is, Novelty, non-obviousness and Industrial applicability or non-patentability criteria mentioned under Sections 3 and 4 of Indian Patent Act. In this chapter, the authors have discussed few of the cases of rejection under the Indian Patent Act.

show abstract

“…The post-TRIPS period has seen greater investment in R&D (Chittoor et al, 2009; Jagadeesh & Sasidharan, 2014), which has led to product patents related to new dosage forms and an increased focus on new drug discovery (Agarwal, Gupta, & Dayal, 2007; Basant & Srinivasan, 2015). The government-run Council of Scientific and Industrial Research (CSIR) has played a crucial role in this regard; CSIR was responsible for gaining 540 new US patents during 1995–2015, compared with 27 between 1950 and 1993 (Brandl et al, 2015).…”

Section: Evolution Of the Indian Pharmaceutical Industry And Key Instmentioning

confidence: 99%

Knowledge Sources and International Business Activity in a Changing Innovation Ecosystem: A Study of the Indian Pharmaceutical Industry

2019

View full text Add to dashboard Cite

The Indian pharmaceutical industry has experienced rapid growth, becoming the world's largest provider of generic drugs, based on product and process innovation. The industry has undergone dynamic changes in recent decades, operating in a rapidly evolving environment affected by domestic and global policies; a key example of the latter is the TRIPS agreement. Taking an intellectual property perspective, we describe how changes in the innovation ecosystem have affected companies’ strategies related to international activity and accessing knowledge from both internal and external knowledge sources, during the transitional- and post-TRIPS periods (1995–2004 and 2005–2014, respectively). Combining intellectual property arguments with contextual aspects of the innovation ecosystem, we conjecture that, in the post-TRIPS period, externally-sourced knowledge will be more important than internally-sourced knowledge, for Indian pharmaceutical firms’ international business activity.

show abstract

Intellectual property protection in India and implications for health innovation: emerging perspectives

Cited by 7 publications

References 31 publications

Exploring Linkages between Industrial Innovation and Public Policy: Challenges and Opportunities

Exploring Linkages between Industrial Innovation and Public Policy: Challenges and Opportunities

Case Study on Rejected Patents in India

Knowledge Sources and International Business Activity in a Changing Innovation Ecosystem: A Study of the Indian Pharmaceutical Industry

Contact Info

Product

Resources

About